期刊文献+

家族性腺瘤性息肉病中COX-2的表达分析 被引量:3

Analysis of cyclooxygenase-2 expression in patients with familial adenomatous polyposis
下载PDF
导出
摘要 目的:分析环氧化酶2(COX-2)在家族性腺瘤性息肉病(FAP)中的表达,探讨COX-2在腺瘤形成以及癌变过程中的可能作用。方法:收集我科2001年1月至2003年6月10例FAP患者手术切除标本,分别取≤0.5 cm、≥1 cm的腺瘤性息肉以及癌变腺瘤组织,采用EnVision免疫组化方法观察COX-2在这些病灶中的表达。结果:COX-2主要在上皮细胞内表达,在部分间质细胞中也表达。COX-2在≤0.5 cm腺瘤上皮细胞中的表达强于正常上皮,但相差并不显著;在≥1.0 cm腺瘤中表达显著强于正常上皮(P<0.01);在不同大小腺瘤之间的表达差异显著,≥1.0 cm腺瘤中表达强于≤0.5 cm腺瘤(P<0.01);癌变腺瘤中的COX-2表达显著高于正常上皮(P<0.01);癌变腺瘤中表达强于≥1.0 cm的腺瘤组织,但相差并不显著。结论:COX-2可能是FAP发展中的重要促进因子,参与了腺瘤早期形成以及癌变过程;选择性抑制COX-2是预防治疗FAP的有效靶点。 Objective:To analyze the expression of cyclooxygenase-2(COX-2) in patients with familial adenomatous polyposis and to discuss the possible role of COX-2 in adenoma formation and cancerization. Methods: The adenoma specimens were obtained from 10 FAP patients (2001-2003). Different sizes (≤0.5 cm and ≥1 cm) of adenomas and cancerous adenomas were subjected to Envision immunohistochemistry for analysis of COX2 protein expression. Results: COX2 was mainly detected in epithelial cells, with some in interstitial cells. When ≤0.5 cm, COX-2 expression in adenomatous epithelial cells was stronger than in normal epithelial cells (P〉 0.05); the same was true when ≥1.0 cm, but with statistical significance (P〈0.01). The expression of COX-2 in different sizes of adenomas was significantly different(P〈0.01), with that in ≥1.0 cm adenomas stronger than that in ≤0.5 cm adenomas. Expression of COX-2 in cancerous adenoma was stronger than that in normal epithelial cells (P〈0.01) and epithelial cells of ≥1.0 cm adenomas (P〉0.05). Conclusion: COX-2 may be a stimulative factor in the progression of FAP and may participate in adenoma formation and cancerization. Selective inhibition of COX2 may be an effective strategy for preventing FAP.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2006年第4期370-372,共3页 Academic Journal of Second Military Medical University
关键词 腺瘤息肉病 结肠 环氧化酶2 adenomatous polyposis coli cyclooxygenase-2
  • 相关文献

参考文献11

  • 1Herendeen JM,Lindley C.Use of NSAIDs for the chemoprovention of colorectal cancer[J].Oncology,2003,37:1664-1674.
  • 2Kawai N,Tsujii M,Tsuji S.Cyclooxygenases and colon cancer[J].Prostaglandins Other Lipid Mediat,2002,68-69:187-196.
  • 3Dempke W,Rie C,Grothey A.Cyclooxygenase-2:a novel target for cancer chemotherapy[J]? J Cancer Res Clin Oncol,2001,127:411-417.
  • 4Williams CS,Luongo C,Radhika A,et al.Elevated cyclooxygenase-2 levels in Min mouse adenomas[J].Gastroenterology,1996,111:1134-1140.
  • 5Takeda H,Sonoshita M,Oshima H,et al.Cooperation of cyclooxygenase 1 and cyclooxygenase 2 in intestinal polyposis[J].Cancer Res,2003,63:4872-4877.
  • 6Khan KN,Masferrer JL,Woerner BM,et al.Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon[J].Scand J Gastroenterol,2001,36:865-869.
  • 7Yamauchil T,Watanabel M,Kubotal T,et al.Cyclooxygenase-2 expression as a new marker for patients with colorectal cancer[J].Dis Colon Rectum,2002,45:98-103.
  • 8Jacohy RF,Seibert K,Cole CE,et al.The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis[J].Cancer Res,2000,60:5040-5044.
  • 9DuBios RN,Shao J,Tsujii M,et al.G1 delay in cells overexpression prostaglandin endoperoxide synthase-2[J].Cancer Res,1996,56:733-777.
  • 10Tsujii M,Kawano S,DuBois RN.Cyclooxyenase-2 expression in human colon cancer cells increases metastatic potential[J].Proc Natl Acad Sci USA,1997,94:3336-3340.

同被引文献52

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部